Krivulka Joseph J 4
4 · AEOLUS PHARMACEUTICALS, INC. · Filed Mar 6, 2013
Insider Transaction Report
Form 4
Krivulka Joseph J
Director
Transactions
- Award
Non-qualified Stock Option (right to buy)
2011-11-07+11,250→ 11,250 totalExercise: $0.40Exp: 2021-11-07→ Common Stock (11,250 underlying) - Award
Non-qualified Stock Option (right to buy)
2012-03-20+11,250→ 11,250 totalExercise: $0.31Exp: 2022-03-20→ Common Stock (11,250 underlying) - Award
Non-qualified Stock Option (right to buy)
2012-07-11+11,250→ 11,250 totalExercise: $0.23Exp: 2022-07-11→ Common Stock (11,250 underlying) - Award
Non-qualified Stock Option (right to buy)
2012-10-09+11,250→ 11,250 totalExercise: $0.35Exp: 2022-10-09→ Common Stock (11,250 underlying)
Footnotes (1)
- [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.